IRB Fees

The Human Research Protections unit in the Office of Research will charge Institutional Review Board (IRB) fees for new clinical research submissions that are partially or fully supported by industry sponsors, including chart review studies. 

The current IRB fee structure is:

Initial Review - Full Committee: $2200.00
Initial Review - Expedited: $1000.00
Continuing Review - Full Committee: $825.00
Continuing Review - Expedited: $500.00
Continuing Review - 7 Year De Novo - Full Committee: $1500.00

IRB Applications that were received prior to April 1, 2012 remain on the old fee structure:

Initial Review - Full Committee: $1500.00
Initial Review - Expedited: $500.00
Continuing Review - Full Committee: $500.00
Continuing Review - Expedited: $500.00
Continuing Review - 7 Year De Novo - Full Committee: $500.00

Important Information to Know About IRB Fees:

• IRB fees are assessed once the research is approved by the IRB.  If the agreement is finalized the fees will be recharged to the study account. 
  
  • For recharges, e-mail notification is provided to the investigator and the department business office regarding the amount and date of each charge.  If the agreement is not finalized, IRB fees will be invoiced directly to the department. 
• IRB fees are charged on investigator-authored studies that are partially or fully supported by an industry sponsor.
• IRB fees are not charged for exempt research, or for modifications/amendments to approved studies.
• IRB fees are not assessed on clinical research that is fully supported by the National Institutes of Health, or other governmental or non-profit entities.
• If UCI defers review to an independent IRB (e.g., Western IRB), UCI IRB charges the expedited review rate for administrative review and oversight.
• When preparing budgets for new clinical research studies, investigators should include the IRB fees to be incurred during each year of the study. These fees are in addition to any costs the investigator or department charges for administrative activities provided by the study team.
• For studies approved prior to January 2014, the IRB Fee assessment will not change.  For example, studies that are partially supported by an industry sponsor will not be charged IRB fees.  Also departments will not be invoiced for studies approved where the agreement was never finalized.
• If you have questions about the new IRB Fee structure contact Karen Allen, Executive Director of Research Protections at 949-824-1558 or karen.allen@uci.edu.